The zebrafish is a versatile model organism with the potential to contribute to our understanding of the molecular pathological mechanisms underlying Alzheimer's disease (AD). An early characteristic of AD brain pathology is lipid peroxidation resulting from oxidative stress. However, changes in lipid peroxidation have not yet been assessed in zebrafish brains, and an earlier attempt to observe changes in F2-isoprostane levels in the brains of zebrafish exposed to hypoxia was unsuccessful. In this article, we examine the utility of various assays of lipid peroxidation and more general assays of intracellular oxidative stress to detect the changes in oxidative stress in the brains of adult zebrafish exposed to hypoxia or explanted into a sodium azide solution for chemical mimicry of hypoxia. Levels of F2-isoprostanes and F4-neuroprostanes were low and variable in zebrafish brains such that statistically significant changes due to hypoxia or chemical mimicry of hypoxia could not be observed. However, measurement of lipid hydroperoxides did reveal significant changes in lipid peroxidation under these conditions, while analyses of catalase gene expression and an assay based on 2′,7′-dicholorofluorescein oxidation also revealed changes in oxidative stress levels.
Get full access to this article
View all access options for this article.
References
1.
Herculano-HouzelS. Scaling of brain metabolism with a fixed energy budget per neuron: implications for neuronal activity, plasticity and evolution. PLoS One, 2011; 6:e17514.
2.
BealMF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol, 1995; 38:357–366.
3.
AtkinsonL, et al.Chronic hypoxia inhibits Na+/Ca2+ exchanger expression in cortical astrocytes. Neuroreport, 2006; 17:649–652.
4.
BellEL, et al.The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J Cell Biol, 2007; 177:1029–1036.
5.
StoneJ. What initiates the formation of senile plaques? The origin of Alzheimer-like dementias in capillary haemorrhages. Med Hypotheses, 2008; 71:347–359.
6.
TamagnoE, et al.NT2 neurons, a classical model for Alzheimer's disease, are highly susceptible to oxidative stress. Neuroreport, 2000; 11:1865–1869.
7.
GuglielmottoM, TamagnoE, DanniO. Oxidative stress and hypoxia contribute to Alzheimer's disease pathogenesis: two sides of the same coin. ScientificWorldJournal, 2009; 9:781–791.
8.
GuglielmottoM, et al.Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors. Front Aging Neurosci, 2010; 2:3.
9.
MoreiraPI, et al.Oxidative stress: the old enemy in Alzheimer's disease pathophysiology. Curr Alzheimer Res, 2005; 2:403–408.
10.
MorrowJD, et al.A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A, 1990; 87:9383–9387.
11.
MorrowJD, HarrisTM, RobertsLJ2nd. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal Biochem, 1990; 184:1–10.
12.
ZhangZJ. Systematic review on the association between F2-isoprostanes and cardiovascular disease. Ann Clin Biochem, 2013; 50(Pt 2):108–114.
13.
StafforiniDM, et al.Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. J Biol Chem, 2006; 281:4616–4623.
14.
SimopoulosAP. Summary of the conference on the health effects of polyunsaturated fatty acids in seafoods. J Nutr, 1986; 116:2350–2354.
15.
SkinnerER, et al.Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects. Brain, 1993; 116(Pt 3):717–725.
16.
MooreSA, et al.Astrocytes, not neurons, produce docosahexaenoic acid (22:6 omega-3) and arachidonic acid (20:4 omega-6). J Neurochem, 1991; 56:518–524.
17.
ConnorWE, NeuringerM, ReisbickS. Essential fatty acids: the importance of n-3 fatty acids in the retina and brain. Nutr Rev, 1992; 50(Pt 2):21–29.
18.
YaoY, et al.Enhanced brain levels of 8,12-iso-iPF2alpha-VI differentiate AD from frontotemporal dementia. Neurology, 2003; 61:475–478.
19.
MontineTJ, et al.Increased CSF F2-isoprostane concentration in probable AD. Neurology, 1999; 52:562–565.
20.
SimonianNA, CoyleJT. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol, 1996; 36:83–106.
21.
KnightJA. Reactive oxygen species and the neurodegenerative disorders. Ann Clin Lab Sci, 1997; 27:11–25.
22.
GerlaiR, et al.Drinks like a fish: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects. Pharmacol Biochem Behav, 2000; 67:773–782.
23.
GrossmanL, et al.Characterization of behavioral and endocrine effects of LSD on zebrafish. Behav Brain Res, 2010; 214:277–284.
24.
CachatJ, et al.Measuring behavioral and endocrine responses to novelty stress in adult zebrafish. Nat Protoc, 2010; 5:1786–1799.
25.
BarbazukWB, et al.The syntenic relationship of the zebrafish and human genomes. Genome Res, 2000; 10:1351–1358.
26.
Moussavi NikSH, et al.The BACE1-PSEN-AβPP regulatory axis has an ancient role in response to low oxygen/oxidative stress. J Alzheimers Dis, 2012; 28:515–530.
27.
Moussavi NikSH, NewmanM, LardelliM. The response of HMGA1 to changes in oxygen availability is evolutionarily conserved. Exp Cell Res, 2011; 317:1503–1512.
28.
WesterfieldM. The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio rerio). 5 ed. Eugene, OR: University of Oregon Press, 2007.
29.
BragaMM, et al.Evaluation of spontaneous recovery of behavioral and brain injury profiles in zebrafish after hypoxia. Behav Brain Res, 2013; 253:145–151.
30.
OgerC, et al.The handy use of Brown's P2-Ni catalyst for a skipped diyne deuteration: application to the synthesis of a [D4]-labeled F4t-neuroprostane. Chemistry, 2010; 16:13976–13980.
31.
DurandT, et al.Total synthesis of 4(RS)-F-4t-isoprostane methyl ester. Tetrahedron Lett, 2000; 41:3859–3862.
32.
MasE, et al.Effects of spinal or general anesthesia on F(2)-isoprostanes and isofurans during ischemia/reperfusion of the leg in patients undergoing knee replacement surgery. Free Radic Biol Med, 2011; 50:1171–1176.
33.
MoriTA, et al.An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry. Anal Biochem, 1999; 268:117–125.
34.
TangR, et al.Validation of zebrafish (Danio rerio) reference genes for quantitative real-time RT-PCR normalization. Acta Biochim Biophys Sin (Shanghai), 2007; 39:384–390.
35.
LeBelCP, IschiropoulosH, BondySC. Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol, 1992; 5:227–231.
36.
TsengYC, et al.Exploring uncoupling proteins and antioxidant mechanisms under acute cold exposure in brains of fish. PLoS One, 2011; 6:e18180.
37.
JinY, et al.Cypermethrin has the potential to induce hepatic oxidative stress, DNA damage and apoptosis in adult zebrafish (Danio rerio). Chemosphere, 2011; 82:398–404.
38.
HermannAC, et al.Development of a respiratory burst assay using zebrafish kidneys and embryos. J Immunol Methods, 2004; 292:119–129.
39.
SeibtKJ, et al.MK-801 alters Na+, K+-ATPase activity and oxidative status in zebrafish brain: reversal by antipsychotic drugs. J Neural Transm, 2012; 119:661–667.
40.
MakridesM, et al.Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am J Clin Nutr, 1994; 60:189–194.
41.
SolbergR, et al.Resuscitation with supplementary oxygen induces oxidative injury in the cerebral cortex. Free Radic Biol Med, 2012; 53:1061–1067.
42.
GirottiAW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res, 1998; 39:1529–1542.
43.
RosaCE, et al.Metabolic rate and reactive oxygen species production in different genotypes of GH-transgenic zebrafish. Comp Biochem Physiol B Biochem Mol Biol, 2008; 149:209–214.
44.
AlievG, et al.Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease. Neurotox Res, 2003; 5:491–504.
45.
AlievG, et al.Hypoperfusion, mitochondria failure, oxidative stress, and Alzheimer disease. J Biomed Biotechnol, 2003; 2003:162–163.
46.
NgF, et al.Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol, 2008; 11:851–876.
47.
ButterfieldDA, Bader LangeML, SultanaR. Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease. Biochim Biophys Acta, 2010; 1801:924–929.
48.
LeeJ, et al.Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington's disease mice. Acta Neuropathol, 2011; 121:487–498.
LauderbackCM, et al.The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J Neurochem, 2001; 78:413–416.
51.
MarkesberyWR, et al.Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol, 2005; 58:730–735.
52.
PraticoD, SungS. Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J Alzheimers Dis, 2004; 6:171–175.
53.
PraticoD, et al.Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch Neurol, 2002; 59:972–976.
54.
HalliwellB, LeeCY. Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues. Antioxid Redox Signal, 2010; 13:145–156.
55.
ChungML, LeeKY, LeeCY. Profiling of oxidized lipid products of marine fish under acute oxidative stress. Food Chem Toxicol, 2013; 53:205–213.
56.
HayashiT, et al.Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide. Free Radic Biol Med, 2007; 43:1552–1559.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
